A Randomized Controlled Trial of an Antiretroviral Treatment Adherence Intervention for HIV+ African Americans

Completed · Not applicable

Conditions studied: HIV/AIDS

In brief

Project Rise is a randomized controlled trial (RCT) of an innovative, culturally congruent treatment education (TE) intervention for African Americans with HIV that targets cultural and social issues contributing to health disparities.

Key facts

Study ID

NCT03331978

Run by

RAND

People needed

306

Starts

2018-01-23

Expected to finish

2021-11-07

Last updated by the study team

2023-01-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV-positive
• 18 years of age or older
• Self-identified as African American/Black
• Been prescribed antiretroviral therapy (ART) in the past 12 months
• Self-reported adherence problems (i.e. missed at least 1 ART dose in the past month) and/or detectable viral load
• Willing to use Medication Events Monitoring System (MEMS) for electronic adherence monitoring.

You may not qualify if…

• HIV-negative
• 17 years of age or younger
• Not self-identified as African American/Black, not on antiretroviral therapy (ART) or not prescribed ART therapy in the last than 12 months
• No self-reported adherence problems and/or no detectable viral load
• Not willing to use Medication Events Monitoring System (MEMS) for electronic adherence monitoring.

Where it is running

• AIDS Project Los Angeles — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.